Sagut, Jimmy A.
HRN: 21-74-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2022
CEFTAZIDIME 1GM (VIAL)
08/16/2022
08/23/2022
IV
2gms
Q8
Copd In Exacerbation; Decubitus Ulcer; Recurrent Fever
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes